Canada Pension Plan Investment Board’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
Other funds holding OCUL
DTC
ACA
SR
VA
Canada Pension Plan Investment Board's OCUL Position: Q1 2026 in Review
Canada Pension Plan Investment Board sold out of Ocular Therapeutix (OCUL) in Q1 2026, closing a stake of 35,200 shares — an estimated $427K sold.
Canada Pension Plan Investment Board first reported a position in OCUL in Q4 2024 and held it in 4 quarters. The position peaked at $600K in Q1 2025. 271 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.
- Canada Pension Plan Investment Board reported no remaining Ocular Therapeutix position as of Q1 2026 after selling out during the quarter.
- Canada Pension Plan Investment Board sold 35,200 Ocular Therapeutix shares in Q1 2026, an estimated $427K.
- Canada Pension Plan Investment Board first reported a position in Ocular Therapeutix in Q4 2024 and held it in 4 quarters.
- Canada Pension Plan Investment Board's Ocular Therapeutix position peaked at $600K in Q1 2025.
- 271 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.
Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.